Non-Invasive Assessment of Systolic and Diastolic Left Ventricular Hemodynamic Forces in Mitral Regurgitation Patients Using Four-Dimensional-Flow Magnetic Resonance Imaging

Mitral regurgitation (MR) remains one of the most prevalent and clinically significant valvular heart diseases globally, with a diverse range of etiologies and a complex pathophysiology that challenges diagnosis and management. While advances in imaging have improved our ability to characterize valvular anatomy and function, the dynamic, intraventricular forces that govern cardiac performance—known as hemodynamic forces (HDFs)^1,2—remain an underutilized but potentially transformative parameter in clinical cardiology.

In this issue, the study by Ghosh Srabanti et al ³ explores a compelling application of four-dimensional flow magnetic resonance imaging (4D-flow MRI^4,5) to quantify left ventricular HDF in patients with MR. Through retrospective analysis, the authors evaluated HDF in multiple directions—particularly along the basal-apical axis—across a cohort of patients with varying degrees of MR severity. Their results shed light on the physiologic underpinnings of MR and propose novel, noninvasive metrics for characterizing disease burden.

Several key findings warrant particular attention. First, the authors demonstrate that both systolic and diastolic HDF are significantly altered in MR patients compared to controls, suggesting that MR not only perturbs valve dynamics but fundamentally impact intracardiac force patterns and thus left ventricular function. Importantly, the study identifies peak-systolic and early diastolic HDF in the basal-apical direction as significant markers of severe MR. These directional forces correlate not only with MR severity but also with cardiac structural parameters such as ejection fraction, indexed LV mass, and also with age in moderate-to-severe cases.

This work contributes valuable mechanistic insight and suggests practical implications for patient care. The ability to noninvasively characterize altered flow dynamics opens a promising avenue for improving risk stratification, monitoring disease progression, and potentially predicting therapeutic response in MR. Moreover, these findings raise the possibility that HDF-based metrics may complement or enhance traditional volumetric and structural imaging assessments, particularly in cases where conventional parameters fall short in guiding clinical decisions.

Importantly, this study also illustrates the growing role of advanced imaging techniques in precision cardiology. 4D-flow MRI has evolved from a research tool into a more broadly available clinically viable technique that can provide detailed, reproducible assessments of cardiac flow and function. The integration of HDF analysis could provide important new insights for biomechanical phenotyping in valvular heart disease.

While the study presents important insights into the role of HDF in MR, several questions remain. The sample size was relatively small, particularly within the MR subgroups, which included only six patients with secondary MR. The relatively wide age range and the retrospective design may also introduce selection bias and confounding variables that are difficult to fully control in observational analyses. Larger, prospective studies are needed to validate these findings and establish normative thresholds for HDF parameters in MR.

Second, although 4D-flow MRI is a new and innovative approach to cardiovascular imaging, it remains a resource-intensive in routine clinical practice. Variability in acquisition protocols, scanner models, and post-processing tools may impact reproducibility across institutions. While the authors used standardized software (Segment, Medviso), intra- and inter-observer variabilities in HDF quantification were not assessed and could influence the robustness of directional force estimates.

Further, the study did not include longitudinal follow-up. As a result, the interplay between HDF changes and clinical outcomes, including symptom burden, functional capacity, and response to surgical or transcatheter intervention should be further elucidated. Prospective, longitudinal data are needed to determine whether the identified HDF markers hold clinical value beyond diagnostic stratification.

Lastly, while the study identifies directional forces associated with MR severity, the mechanistic interpretation of these force alterations remains speculative. The relationship between these forces and underlying myocardial remodeling, valve mechanics, or compensatory adaptation is not fully understood, and further biomechanical modeling studies may be needed to clarify these connections.

Nonetheless, the study provides valuable new data for future research in this emerging area of cardiac biomechanics. This study represents an important step forward in the functional assessment of MR and exemplifies how advances in imaging technology such as 4D flow MRI can reshape our understanding of cardiovascular disease. The identification of specific HDF patterns as markers of MR severity highlights a promising diagnostic and prognostic tool that may enrich clinical practice. The authors are commended for their innovative work and anticipate that this will catalyze further research into the hemodynamic signatures of valvular disease.